SCHEMBL7913077

SCHEMBL7913077

Nc1c(Nc2cccc(-c3nc4ccccc4[nH]3)c2)c(=O)c1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.57
SMN1; SMN2 Q16637 7/20 0.57
ALDH1A1 P00352 7/20 0.57
KMT2A Q03164 4/20 0.57
MEN1 O00255 3/20 0.57
HPGD P15428 5/20 0.56
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
HSD17B10 Q99714 3/20 0.56
TP53 P04637 2/20 0.56
MAPT P10636 6/20 0.56
POLB P06746 3/20 0.56
THRB P10828 1/20 0.56
RECQL P46063 1/20 0.56
ATM Q13315 1/20 0.56
MMP2 P08253 4/20 0.55
MMP9 P14780 4/20 0.55
MMP8 P22894 4/20 0.55
MMP13 P45452 3/20 0.55
COMT P21964 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31592975 0.79 MMP2 (0.64) KDM4ESMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7913073 0.78 NPC1 (0.48) KDM4ESMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL30726447 0.77 MMP2 (0.62) KDM4ESMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7913085 0.77 VCP (0.46) KDM4EALDH1A1KMT2AMEN1POLB
SCHEMBL7905830 0.76 SIRT2 (0.48) KDM4EALDH1A1KMT2AMEN1MAPT
SCHEMBL28917234 0.75 KDM4E (0.64) KDM4ESMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL27039896 0.74 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL31592814 0.74 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL3417301 0.74 NPC1 (0.78) KDM4ESMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL31063849 0.73 ALDH1A1 (1.00) KDM4ESMN1; SMN2ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211220-B1 ANTITUMOR AGENTS AND ANTICARCIINOGENIC AGENTS CELL PATHWAYS, INC. 2001-04-03 US claimed
US-6211220-B1 ANTITUMOR AGENTS AND ANTICARCIINOGENIC AGENTS CELL PATHWAYS, INC. 2001-04-03 US disclosed
WO-1994029277-A1 AMILINO- OR PYRIDYLAMINO- CYCLOBUTENE- 1,2-DIONE DERIVATIVES AS cGMP PHOSPHODIESTERASE INHIBITORS SMITHKLINE BEECHAM PLC (GB) 1994-12-22 WO disclosed